GLP‑1 Price Tracker Review: How pricetrackerglp1.com Checks GLP‑1 Prices

PriceTracker GLP-1 is a price-comparison site for online GLP-1 weight-loss programs in the US. Its about page names Julian Caraulani as founder and says he owns the methodology: which programs are tracked, how a price gets verified and what the index number means.2 He is not a clinician, and the site says it does not write clinical guidance.2 A named medical reviewer, Dr. A. Goher, MD, reviews the clinical statements on the site only; she does not review prices, rankings or the site's commercial relationships.2

The home page is a price board: programs ranked cheapest first, filterable by drug (semaglutide, tirzepatide, Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo and needle-free options), by insurance and by whether you already have a prescription.1 Around it sit a monthly price index, a week-by-week price-change log, an open dataset, drug and coverage guides, cost tools and a video library.1

Every price on the board includes membership fees, so the number is the monthly amount you would pay.2 Each price is quoted from the seller's own page with the date it was read, and a price the site cannot verify is not published.2 As of October 2026, the site had made 474 price checks since August 2026 across 22 programs and 205 tracked prices.3

The methodology sets out four steps for every number: the source URL and a verbatim quote of the sentence that states the price, the date it was verified, an append-only history where a change adds a new point instead of rewriting the old one, and a sanity gate that holds any price moving more than 40% in one check for human review.3 When a provider publishes no pricing, its page says "not verified yet" instead of showing a guess.3

Every list on the site is ordered by price alone, and the site says commission never moves a rank.3,4 Each program also gets a score out of 10, built from five factors: price counts for 35% of the score, flexibility for 20%, fees on top for 15%, patient reviews (Trustpilot) for 20% and reach across the 50 states for 10%.3 The score never changes the order of a list.3

The GLP-1 Price Index is the median all-in monthly price across the programs it tracks. Recomputed from data checked October 21, 2026, it stood at $159 a month, with a floor of $69 (SnagRx) and a ceiling of $299 (Willow), each program counted once at its cheapest offer.5 The index page also publishes a "fair cash price" per product: $185 a month for compounded semaglutide injection at the starting dose, month to month, across 18 programs.5 The index chart separates observed data since August 2026 from a modeled reconstruction before it, and says only the observed section is data.5

The price-changes page counts only a change between two consecutive weekly reads of a seller's pricing page, and does not count a new, cheaper prepaid plan as a price drop when the monthly price did not move.6 By that rule it had recorded three genuine entry-price changes across 22 programs since August 2026, such as CoreAge Rx moving from $99 to $79 in October.6

The full dataset, one row per medication, dose and plan length with the date read and the source page, can be downloaded as CSV or JSON under a CC BY 4.0 license.7 The October 21, 2026 version held 119 prices across 22 programs.7

GLP-1 TV is a library of 1,548 videos curated from YouTube, sorted by drug, topic and who is speaking (patient, clinician, news), and labeled "nothing sponsored."8 The tools section includes an insurer coverage checker, a Medicare GLP-1 Bridge checker, a state-by-state program finder and a titration cost schedule.1

1. Pick your drug on the board. Choose semaglutide, tirzepatide or a brand, and set your insurance and prescription status.1
2. Read the plan term next to the price. The board shows a monthly equivalent, and some entries are prepaid plans: in October 2026, Embody's $69 a month was a 12-month plan paid up front at $828.1
3. Open the program page for the full menu by dose and term, with the date each price was read.3
4. Check the seller's own page before you pay. Each price links to it.1

• It tracks partner programs. The methodology says the site lists and links only programs it partners with.3 Its disclosure adds that programs it does not earn from, such as manufacturer-direct channels, are listed when they are relevant to your cost.4 The board is not the whole market.
• It earns commissions. Some programs pay the site a commission when a reader signs up through its links.4 Its featured "Our pick" (Embody in October 2026) is labeled on the home page as "a commercial choice."1
• The headline is the cheapest offer. The price shown for a program is its cheapest advertised monthly price.6 Check the program page for the dose and plan you would actually be prescribed, or use the titration cost tool, which prices every monthly fill.1
• Its own history is young. Observed price data starts in August 2026.5
• It is not a medical resource. The site states: "We track prices; we do not give medical advice."2 It is not a pharmacy, a telehealth provider or a doctor.4

The cheapest offer on the board in October 2026, SnagRx at $69 a month, was compounded semaglutide.5 Compounded GLP-1s are prepared by a pharmacy to a prescription, and they are not FDA-approved: the FDA doesn't review their safety, effectiveness or quality before they're sold.9

The two sites agree on the most important thing about price: a monthly figure should include the membership fee. PriceTracker GLP-1 is the more focused tool for watching prices move week to week, and its index and change log are a good way to see where the market sits. glp1.health covers more than price. Each glp1.health review carries a glp1.health Score with its breakdown and confidence level, checks the program against FDA warning letters, and cites every claim to a numbered source. Our /best rankings and /compare table also price each program with its membership fees included, and the glp1.health price index sets the list price of every semaglutide and tirzepatide product beside its cash price.

If price is your first question, PriceTracker GLP-1 answers it quickly. If you also want to know about a program's safety record, pharmacy and terms, read its glp1.health review before you sign up.

What is the GLP-1 Price Tracker? PriceTracker GLP-1 (pricetrackerglp1.com) is a free site that reads 22 US telehealth GLP-1 programs weekly from their own pages and ranks them by all-in monthly price, membership fees included.2

How often does PriceTracker GLP-1 update prices? Weekly. Entry prices and full menus are re-read every week, and other facts monthly, according to its methodology.3

Is PriceTracker GLP-1 free? Yes. It is free to use and earns a commission when a reader signs up with some programs through its links, at no extra cost to the reader.4

Does commission change the rankings? The site says it does not: every list is ordered by price alone, and providers cannot pay to move up.3,4 Its "Our pick" spot is labeled as a commercial choice.1

Who runs PriceTracker GLP-1? Its about page names Julian Caraulani as founder.2

This article is for information only and is not medical or financial advice. Details about PriceTracker GLP-1 were read from its own pages on October 22, 2026 and may have changed. Talk to a licensed clinician about whether a GLP-1 is right for you, and confirm the price and terms with the program before you pay.